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Neuronal Ca 2 influx via NMDA receptors (NMDARs) is essential for the development and plasticity of synapses but also triggers
excitotoxic cell death when critical intracellular levels are exceeded. Therefore, finely equilibrated mechanisms are necessary to ensure
that NMDAR function is maintained within a homeostatic range. Here we describe a pronounced difference in the modulation of NMDA
currents in two closely related hippocampal cell types, the CA1 and the CA3 pyramidal cells (PCs). Manipulations that increase intracel-
lular Ca 2 levels strongly depressed NMDA currents in CA3 with only minor effects in CA1 PCs. Furthermore, activation of Gq-coupled
metabotropic receptors potentiated NMDA currents in CA1 PCs but depressed them in CA3 PCs. Interestingly, the CA3 type modulation
of NMDARs could be converted into CA1-like behavior, and vice versa, by increasing Ca 2 buffering in CA3 cells or decreasing Ca 2
buffering in CA1 cells, respectively. Our data suggest that a differential Ca 2 sensitivity of the regulatory cascades targeting NMDARs
plays a key role in determining the direction and magnitude of NMDA responses in various types of neurons. These findings may have
important implications for NMDA receptor-dependent synaptic plasticity and the differential sensitivity of CA1 and CA3 PCs to NMDAR-
dependent ischemic cell death.
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Introduction
NMDA receptors (NMDARs) are glutamatergic ionotropic re-
ceptors that act as gatekeepers for the influx of dendritic Ca 2
during synaptic activity. Reflecting the importance of Ca 2 entry
via NMDARs, several regulatory pathways exist that meticulously
control NMDAR activity. Potentiation of NMDARs can be
achieved by activating one of several transduction cascades that
converge on Src kinase resulting in tyrosine phosphorylation of
the receptor (Kotecha and MacDonald, 2003). This mechanism,
which is triggered by the activation of metabotropic receptors,
increases the open probability without changing the unitary con-
ductance of NMDAR channels (Yu et al., 1997; Ali and Salter,
2001). Depression of NMDARs occurs through a negative feed-
back loop that promotes desensitization and inactivation of
NMDARs as intracellular Ca 2 rises (Kotecha and MacDonald,
2003). Because the activation of metabotropic receptors induces
both Src activation and release of Ca 2 from intracellular stores,
it is difficult to predict whether the final outcome on NMDARs
will be upregulation or downregulation. In fact, depending on the
cell type and experimental conditions, either potentiation or de-
pression of NMDA currents has been reported after activation of
metabotropic receptors (Benquet et al., 2002; Kotecha and Mac-
Donald, 2003).
In this study, we investigated the interactions between intra-
cellular transduction pathways mediating positive and negative
regulation of NMDARs. We found marked differences in the
Ca 2-sensitive metabotropic modulation of NMDARs between
CA1 and CA3 pyramidal cells (PCs).
Materials and Methods
Slice culture preparation and electrophysiology. Hippocampal organotypic
slices were prepared from postnatal day 6 Wistar rats using the roller-
tube technique (Gahwiler et al., 1998). After 2– 4 weeks in vitro, slice
cultures were transferred to a 1 ml recording chamber that was perfused
continuously with Tyrode’s solution (1.5 ml/min, 30°C) containing (in
mM): 137 NaCl, 2.7 KCl, 11.6 NaHCO3, 0.4 NaH2PO4, 0.5 MgCl2, 1.8
CaCl2, 5.6 D-glucose, (in M): 5 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-
benzo[f]quinoxaline-7-sulfonamide (NBQX), 100 picrotoxin, 0.1 tetro-
dotoxin, 0.001% phenol red, pH 7.4, 305 mOsm. Whole-cell voltage-
clamp recordings were obtained from visualized CA1 and CA3 PCs at
50 mV using an Axopatch 200B amplifier (Axon Instruments, Foster
City, CA). Patch pipettes (2–5 M; series resistance 3–15 M) were filled
with (in mM): 140 K-gluconate, 10 HEPES, 1 EGTA, 4 Mg-ATP, 0.4
Na-GTP, pH 7.2, 290 mOsm. Liquid junction potentials (13 mV)
were corrected for. When the Ca 2 buffer concentration was increased,
K-gluconate was reduced to maintain osmolarity. ( S)-3,5-
dihydroxyphenylglycine (DHPG) experiments were performed with 3
mM extracellular Ca 2. Currents were filtered at 1–2 kHz, stored, and
analyzed off-line (pClamp7; Axon Instruments). Intracellular recordings
were made using an Axoclamp-2A amplifier (Axon Instruments) and
40 – 60 Mmicroelectrodes filled with 1 M potassium acetate. Because of
the poor voltage clamp in cells recorded with microelectrodes, NMDA
responses were measured in current-clamp mode.
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NMDA current induction. NMDA (100 M) was pressure ejected
(1 bar) for200 msec from a pipette positioned100m from the soma of
recorded cells. NMDA-induced currents were completely blocked by
40 M (E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid
(CPP). Peak effects of metabotropic agonists (measured after 1–5 min)
were compared with and normalized to the average NMDA current am-
plitude from three to five NMDA puffs immediately preceding agonist
application (referred to as “baseline”). When testing the effects of differ-
ent extracellular Ca 2 concentrations, the MgCl2 concentration was 2
mM. Solutions were changed after NMDA currents reached a steady state
for a given test solution.
Ca2 imaging. Oregon Green 488 BAPTA-2 (20 M) was added to the
intracellular solution (Kd580 nM) and excited at 488 nm using a TILL
Photonics Polychrome I monochromator (Planegg). Emitted images
were collected with a cooled CCD camera (Princeton Instruments, Tren-
ton, NJ) after they were passed through a TILL FITC filter set, stored, and
analyzed using the Axon Imaging Workbench program (Axon Instru-
ments). Images were collected at 10 sec intervals (exposure time 200 –500
msec). Average fluorescence was determined for regions of interest over
the soma (avoiding the nucleus), and the average background fluores-
cence of a region away from the filled cell was subtracted. F/F was
calculated for each image [(average fluorescence average baseline flu-
orescence)/average baseline fluorescence].
Statistics. Data are presented as means SEM. Potentiation or depres-
sion of NMDA currents is given as percentage of the baseline response.
Paired Student’s t tests were used to compare the non-normalized
NMDA currents before and after agonist application. To compare effects
of changing Ca 2 concentration in CA1 and CA3 cells, two-way ANO-
VAs followed by Tukey’s honestly significant difference (HSD) post hoc
tests were used with normalized data (SPSS, Chicago, IL). Values of p
0.05 were considered statistically significant.
Drugs. CPP was kindly provided by Novartis (Basel, Switzerland). Te-
trodotoxin was purchased from Latoxan (Valence, France), NBQX from
AG Scientific (San Diego, CA), DHPG from Tocris Cookson (Avon-
mouth, UK), Oregon Green BAPTA-2 and K4BAPTA were from Molec-
ular Probes (Leiden, Netherlands). Other chemicals were from Sigma (St.
Louis, MO). Stock solutions of NBQX and picrotoxin were prepared in
DMSO, which never exceeded a final concentration of 0.02%.
Results
Differential regulation of NMDA responses in CA1 and CA3
PCs by Ca 2
We compared the effect of changing the extracellular Ca 2 con-
centration on NMDA responses in CA1 and CA3 PCs. Pharma-
cologically isolated NMDA currents were induced in PCs voltage-
clamped at50 mV by pressure application of NMDA at 30 sec
intervals. Increasing the extracellular Ca 2 concentration af-
fected NMDA currents differently in CA1 and CA3 PCs ( p 
0.001; two-way ANOVA) (Fig. 1). Ca 2 (10 mM) strongly de-
pressed NMDA currents in CA3 cells (41.3 4.2% of response in
0.1 mM Ca 2; n 9; p 0.001; Tukey’s HSD) but had much less
effect in CA1 cells (80.2 2.4% of response in 0.1 mM Ca 2; n
8; p 0.001; Tukey’s HSD) (Fig. 1).
Increasing the extracellular Ca 2 concentration is expected to
cause a corresponding increase in intracellular Ca 2 concentra-
tion because of enhanced Ca 2 influx through the repetitively
activated NMDARs and because of a Ca 2 conductance active at
a holding potential of50 mV (Gee et al., 2003). This was con-
firmed by imaging intracellular Ca 2 with Oregon Green 488
BAPTA-2 while simultaneously recording whole-cell currents.
We wished to compare both the basal Ca 2 rises attributable to
changing extracellular Ca 2 and the transient Ca 2 rises caused
by activation of NMDARs in CA3 versus CA1 PCs. To determine
the baseline Ca 2, F/F was calculated from the background-
subtracted images taking the value at 0.1 mM Ca 2 as the base-
line. To calculate the Ca 2 transients associated with NMDAR
activation, the Ca 2 level before each transient was taken as the
baseline. Because extracellular Ca 2 increased, intracellular
Ca 2 increased in both CA1 and CA3 PCs ( p 0.05; n 3 CA1;
n  3 CA3; two-way ANOVA) (Fig. 2A–C), but there was no
difference between CA1 and CA3 PCs ( p 	 0.10). Likewise, the
Ca 2 transients evoked by NMDA increased in both CA1 and
CA3 PCs, reflecting the increased driving force for Ca 2 entry
through the NMDA channels ( p 0.003; n 3 CA1; n 3 CA3;
two-way ANOVA). Again, there was no difference between CA1
and CA3 PCs ( p 	 0.5; two-way ANOVA) (Fig. 2A,B,D,E). In
contrast, the simultaneously recorded NMDA currents were sig-
nificantly more depressed in CA3 than in CA1 PCs ( p 0.5; n
3; two-way ANOVA) (Fig. 1A). Thus, similar manipulation of
intracellular Ca 2 levels results in markedly different Ca 2-
dependent depression of NMDA currents in CA1 and CA3 PCs.
NMDA currents are potentiated in CA1 and depressed in CA3
PCs by metabotropic receptors
Because the above experiments show that the increasing intracel-
lular Ca 2 depresses NMDA currents, we asked whether similar
modulation occurs when intracellular Ca 2 levels are raised by
activating metabotropic Gq-coupled receptors. Activating
metabotropic receptors enhances NMDA currents in hippocam-
pal PCs via a second messenger cascade involving phosphoinosi-
tol hydrolysis and subsequent phosphorylation of NMDA chan-
nels via the protein tyrosine kinase Src (Kotecha and MacDonald,
2003). As expected, we observed that application of the cholin-
ergic agonist muscarine (10 M for 2 min) potentiated NMDA
currents in CA1 PCs (140.6 2.79%; n 5; p 0.01) (Fig. 3A).
In contrast, muscarine induced a transient potentiation followed
by a strong depression of NMDA currents in CA3 PCs obtained
from the same slice cultures (68.2 1.6%; n 5; p 0.01) (Fig.
3A). The potentiation of NMDA currents in CA1 and the depres-
sion in CA3 were reversible after15 min of muscarine washout.
Figure 1. Increasing extracellular Ca 2 reduces NMDA currents more strongly in CA3 than in
CA1 PCs. A, Normalized NMDA current versus extracellular Ca 2 concentration. Note the much
steeper concentration–response curve for CA3 cells. B, NMDA currents in different Ca 2 con-
centrations from a CA1 and a CA3 PC.
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The difference in NMDA receptor modulation in CA1 versus
CA3 PCs was also observed with activation of group I metabo-
tropic glutamate receptors. Application of DHPG (50 M for 2
min), a group I metabotropic glutamate receptor agonist, mark-
edly potentiated NMDA responses in CA1 PCs (134.5 11.4%;
n  5; p  0.05), as described previously (Valenti et al., 2002;
Kotecha and MacDonald, 2003), whereas NMDA responses were
depressed in CA3 PCs (71.8 8.9%; n 6; p 0.05) (Fig. 3B).
These results indicate that increases in intracellular Ca 2 levels
have opposite effects on the metabotropic transduction mecha-
nisms modulating NMDARs in CA3 versus CA1 PCs. This idea
was tested further by examining the effects of changing intracel-
lular Ca 2 buffering on the modulation of NMDA currents in
these two types of PCs.
Intracellular Ca 2 buffering alters metabotropic modulation
of NMDA currents
In CA1 PCs, when Ca 2 buffering was decreased by lowering
intracellular EGTA from 1 to 0.1 mM, muscarine depressed rather
than potentiated NMDA currents (83.3 2.7%; n 5; p 0.05)
(Fig. 4A). Conversely, increasing intracellular Ca 2 buffering
with 30 mM BAPTA prolonged the muscarinic potentiation of
NMDA currents (149.5 11.8%; n 5; p 0.05) (Fig. 4A). In
CA3 PCs, the depression of NMDA currents seen with 1 mM
EGTA intracellularly (71.5  2.0%; n  9; p  0.001) was
Figure 2. Increasing extracellular Ca 2 concentration causes similar increases in intracellular
Ca 2 levels and NMDA-induced Ca 2 transients in CA1 and CA3 PCs, whereas simultaneously re-
corded NMDA currents are strongly depressed only in CA3. A CA1 ( A) and a CA3 ( B) PC were filled with
the Ca 2 indicator Oregon Green 488 BAPTA-2 and fluorescence images were collected every 10 sec.
Top traces show fluorescence signals (background-subtracted arbitrary units) with the simulta-
neously recorded normalized NMDA-induced currents below. Note the transient rises in the fluores-
cence signal corresponding to Ca 2 influx through the NMDARs. Extracellular Ca 2 was changed
where indicated. CPP completely blocked responses to NMDA. C, The increase inF/F relative to the
basal level in 0.1 mM was the same in CA1 (E) and CA3 (F) PCs when extracellular Ca 2 was
increased. D, The change in fluorescence induced by NMDA application increased with increasing
Figure 3. Activating muscarinic or metabotropic glutamate receptors potentiates NMDA
currents in CA1 and depresses NMDA currents in CA3 PCs. A1, Normalized NMDA currents in CA1
(E) and in CA3 (F) PCs from five slices before and after application of muscarine (Musc; 10M).
B1, Effects of DHPG (50 M) on normalized NMDA currents. NMDA currents before and after
application of muscarine (A2) or DHPG (B2) are shown. Pooled maximal effects of muscarine
(A3) or DHPG (B3) are shown (*p 0.05; **p 0.01).
4
Ca 2 concentration in both CA1 and CA3 PCs. E, Sample Ca 2 transients and NMDA currents
from the cells in A and B. Note that NMDA currents are much more sensitive to changes in Ca 2
concentration in CA3 than in CA1 cells. Scale bars: A, B, 20m. E, Ca 2 transients, 2 min; CA1
0.5F/F; CA3 0.1F/F; NMDA currents, 3 sec, 100 pA.
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switched to a significant potentiation with 30 mM BAPTA
(134.3 8.9%; n 6; p 0.01) (Fig. 4B), mimicking the effect of
muscarine on NMDA currents in CA1 PCs loaded with 1 mM
EGTA (compare Fig. 3A). Intermediate Ca 2 buffering with 10
mM EGTA resulted in an intermediate degree of muscarinic mod-
ulation of NMDA responses (125.0 17.4%; n 4; p	 0.10 in
CA3; data not shown). Likewise, the DHPG-induced depression
of NMDA currents in CA3 PCs was converted into potentiation
when intracellular Ca 2 buffering was enhanced with 10 mM
BAPTA (142.8 9.6%; n 5; p 0.05) (Fig. 4B, inset). Thus, the
modulation of NMDARs by muscarinic or metabotropic gluta-
mate receptors depends critically on intracellular Ca 2.
We next examined whether the pronounced Ca 2-dependent
depression of NMDA currents in response to increased extracel-
lular Ca 2 in CA3 PCs is changed by increasing intracellular
Ca 2 buffering. When 30 mM BAPTA was used as the intracellu-
lar buffer, a virtually flat concentration–response curve reminis-
cent of that in CA1 cells was observed (Fig. 4C) (88.0 4.8% of
response in 0.1 mM Ca 2 at 10 mM Ca 2; n  5; p  0.001
two-way ANOVA) (compare Fig. 1A).
To ensure that the differential Ca 2-dependent modulation
of NMDA responses occurs in PCs with unmanipulated Ca 2
buffering, we recorded NMDA-induced depolarizations with
sharp microelectrodes. Under these conditions, Ca 2 buffers are
not introduced into the neurons, and intracellular dialysis is min-
imal. Again we found a significant difference in the modulation
of NMDA responses between both cell types. In response to 1M
muscarine, NMDA responses were strongly and irreversibly po-
tentiated in an long-term potential (LTP)-like manner in CA1
(236.8 38.9%; n 5; p 0.05), whereas in CA3 PCs potenti-
ation was significantly less and of short duration (5– 6 min;
135.1  5.4%; n  5; p  0.01). The fact that we observe this
slight transient potentiation rather than a depression in CA3 PCs
when recording with microelectrodes suggests that intrinsic
Ca 2 buffering in this cell type is greater than that observed with
1 mM EGTA in the patch-clamp experiments and very similar to
the modulation obtained with 10 mM EGTA (1 mM EGTA: 71.5
2.0%; n 9; p 0.001; versus 10 mM EGTA: 125.0 17.4%; n
4; p	 0.10 in CA3; data not shown). These findings confirm that
the differential Ca 2– dependent regulation of NMDA responses
in CA1 versus CA3 PCs is inherent to the cell type.
Discussion
Our experiments show that Ca 2-dependent depression of
NMDA responses is greater in hippocampal CA3 PCs than in
CA1 PCs. This effect was observed by altering intracellular Ca 2
levels through changes in extracellular Ca 2 concentration or by
altering intracellular Ca 2 buffers. Strikingly, this Ca 2-
dependent mechanism resulted in distinct modulation in the two
cell types when activating Gq-coupled metabotropic receptors,
such that activation of muscarinic receptors or metabotropic glu-
tamate receptors typically depressed NMDA responses in CA3
PCs but potentiated them in CA1 PCs.
It is well established that Ca 2 influx through NMDARs trig-
gers a negative feedback process that inactivates NMDA receptors
through the activation of various Ca 2-dependent proteins, in-
cluding calmodulin and Ca 2-dependent phosphatases (Ko-
techa et al., 2003). On the other hand, NMDA responses can be
potently upregulated by activation of Gq-coupled metabotropic
receptors via a protein kinase C (PKC)-dependent (Ben Ari et al.,
1992; Lu et al., 1999; Kotecha and MacDonald, 2003) or a PKC-
independent pathway (Benquet et al., 2002; Heidinger et al.,
2002), both of which culminate in Src-mediated tyrosine phos-
phorylation of NMDARs (Ali and Salter, 2001). Our data dem-
onstrate that both the positive and negative modulatory path-
ways are present and converge on NMDARs in CA1 and CA3 PCs
but that a difference in the balance between opposing signaling
cascades can result in an opposite net modulatory effect. Both
potentiation and depression of NMDA responses after metabo-
tropic glutamate receptor activation have been reported (for re-
view, see Benquet et al., 2002; Kotecha and MacDonald, 2003).
Likewise, stimulation of muscarinic receptors potentiates
NMDARs in CA1 PCs (Markram and Segal, 1990), whereas we
found that depression predominated in CA3 PCs. We propose
that cell type-specific differences in intrinsic Ca 2 signaling or
buffering and the intracellular Ca 2 concentrations set by the
experimental conditions determine which modulatory pathway
prevails and results in either potentiation or depression of
NMDARs by metabotropic receptors.
Although an increase in intracellular Ca 2 concentration pri-
marily depresses NMDARs, very strong Ca 2 buffering blocks
the potentiation (Calabresi et al., 1998; Skeberdis et al., 2001;
Kotecha and MacDonald, 2003). The absolute requirement for
Ca 2 in the potentiating pathways reflects the presence of the
Ca 2-dependent proteins PKC or calmodulin, both of which
activate the tyrosine kinase proline-rich tyrosine kinase-Z/cell-
adhesion kinase- that, in turn, induces Src-dependent phos-
phorylation of NMDARs (Heidinger et al., 2002; Kotecha and
Figure 4. Intracellular Ca 2 buffering changes the polarity and amplitude of metabotropic
modulation of NMDA currents. A, Normalized peak NMDA currents in CA1 PCs with low intracel-
lular Ca 2 buffering (0.1 mM EGTA, F) and high Ca 2 buffering (30 mM BAPTA, E) with
pooled maximal potentiation– depression at right. B, Normalized peak NMDA currents in CA3
PCs with 1 mM EGTAF and high Ca 2 buffering (30 mM BAPTA,E). Inset, DHPG (50M) effect
on NMDA currents in CA3 PCs with 1 mM EGTA (F) or 30 mM BAPTA (E) with pooled maximal
potentiation– depression at right. C, Effects of changing extracellular Ca 2 concentration on
NMDA currents in CA3 PCs. (1 mM EGTA,F; 30 mM BAPTA,‚). D, Normalized NMDA-induced
depolarizations recorded intracellularly in CA1 (E) and CA3 (F) PCs (*p 0.05; **p 0.01;
***p 0.001).
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MacDonald, 2003). Therefore, metabotropic receptor activation
will maximally potentiate NMDARs under physiological condi-
tions when concentrations of intracellular Ca 2 are low, and
shifts in intracellular Ca 2 concentration in either direction will
reduce NMDAR potentiation or induce depression (i.e., a bell-
shaped curve).
The signaling pathways leading to potentiation of NMDARs
have been mapped out in considerable detail. In contrast, the
processes underlying the Ca 2-dependent inactivation of
NMDA receptors are less understood. A number of Ca 2-
dependent proteins, including calmodulin, calcineurin, PKC,
and -actinin-2, are implicated in the regulation of NMDAR
function (Rycroft and Gibb, 2002). Of particular interest in light
of our data are the recent reports that striatal-enriched protein
tyrosine phosphatase (STEP), which is also expressed in hip-
pocampus, is activated by calcineurin as a result of Ca 2 entry
through NMDARs (Paul et al., 2003). Thus, the positive and
negative signaling pathways modulating NMDARs can target the
tyrosine kinase Src and the tyrosine phosphatase STEP, respec-
tively, and bi-directionally control the phosphorylation state of
NMDARs (Pelkey et al., 2002). Low intracellular Ca 2 could
therefore favor the potentiating Src-dependent pathway, in-
creased intracellular Ca 2 could favor NMDAR depression via
STEP, and a lack of Ca 2 would activate neither pathway.
How can the differences in NMDAR modulation in CA1 ver-
sus CA3 PCs be explained? Numerous factors could contribute,
including (1) differential expression of the metabotropic recep-
tors, (2) differential expression of NMDAR subunits, (3) the
presence of different pathways coupling the metabotropic and
NMDA receptors, and (4) differential Ca 2 handling. The first
possibility is unlikely because experimental alteration of Ca 2
concentration, thereby bypassing the metabotropic receptors, led
to stronger depression of NMDA currents in CA3 than in CA1
cells. With respect to the second possibility, immunohistochem-
ical studies report similar expression patterns of NMDA receptor
subunits in CA1 and CA3 PCs in rat hippocampus (Fritschy et al.,
1998), including in slice cultures (Gerfin-Moser et al., 1995). In
CA3 PCs, however, there is marked heterogeneity in NMDA re-
ceptor expression at mossy fiber versus associational fiber syn-
apses (Watanabe et al., 1998) and at apical versus basal dendrites
(Kawakami et al., 2003). It will be interesting to compare the
consequences of metabotropic modulation of NMDARs at spe-
cific synapses in the future. Third, we predict that differences in
the Ca 2 sensitivity of the signaling cascades coupling metabo-
tropic receptors and NMDARs contribute to the differential re-
sponses recorded in CA1 and CA3 PCs. Fourth, our experiments
provide direct evidence that differential Ca 2 handling is critical
in determining the direction of NMDAR modulation in the two
cell types. By manipulating intracellular Ca 2 buffering we were
able, with respect to NMDAR modulation, to convert a CA3 into
a CA1 PC, and vice versa. This finding suggests that there may be
a substantially higher Ca 2 buffering capacity in CA1 PCs. An
attractive candidate for endogenous Ca 2 buffering is calbindin-
D28K, which is expressed in CA1 but not in CA3 PCs (Sloviter,
1989). Furthermore, LTP in CA1 PCs is impaired by a calbindin
deficiency but rescued by chelating intracellular Ca 2 (Jou-
venceau et al., 2002). Our observation of a similar rise in free
intracellular Ca 2 in CA1 and CA3 PCs in response to raising
extracellular Ca 2 appears to argue against a difference in endog-
enous buffering capacity; however, critical signaling events may
occur within functional microdomains with localized differences
in Ca 2 concentration that cannot be resolved against the bulk
changes in cytoplasmic Ca 2 levels or that are inaccessible to the
Ca 2 indicators.
Our findings have a number of functional implications. De-
pending on the intracellular Ca 2 availability, metabotropic re-
ceptors can potentiate or depress NMDARs and therefore can act
as a switch to determine whether synapses undergo long-term
potentiation or long-term depression (Bortolotto et al., 1999).
This mechanism may explain why the threshold for NMDA
receptor-dependent LTP induction is lower at the Schaffer collat-
eral–CA1 synapse than at the associational fiber–CA3 synapse
(Moody et al., 1998). Furthermore, the propensity for NMDARs
to become potentiated in CA1 PCs may explain, in part, the se-
lective vulnerability of these neurons to ischemic cell death
(Schmidt-Kastner and Freund, 1991), whereas in CA3 PCs the
excessive Ca 2 influx during an excitotoxic insult may be neuro-
protective by shutting down NMDARs.
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